Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Tim_Lu
|
| gptkbp:focus |
synthetic biology
cell and gene therapy |
| gptkbp:foundedYear |
2016
|
| gptkbp:founder |
gptkb:Jim_Collins
gptkb:Philip_Lee gptkb:Tim_Lu |
| gptkbp:fullName |
gptkb:Senti_Biosciences,_Inc.
|
| gptkbp:headquartersLocation |
gptkb:South_San_Francisco,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Senti Bio
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:mission |
to engineer next-generation cell and gene therapies using synthetic biology
|
| gptkbp:notableProduct |
gptkb:Senti_BioLogic_platform
CAR-NK cell therapies |
| gptkbp:publiclyTraded |
yes
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:SNTI
|
| gptkbp:website |
https://www.sentibio.com/
|
| gptkbp:bfsParent |
gptkb:Felicis_Ventures
|
| gptkbp:bfsLayer |
5
|